Global Biotechnology Contract Manufacturing Market Size is valued at USD 20.5 Bn in 2024 and is predicted to reach USD 46.6 Bn by the year 2034 at a 8.7% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
A company called a contract manufacturing organization (CMO) is one that contracts out specialized services like drug manufacturing and manufacturing to other businesses in the biopharmaceutical sector. Biotechnology contract manufacturing plays a vital role in the biopharmaceutical industry, allowing companies to focus on research, development, and commercialization while relying on specialized partners for efficient and compliant manufacturing processes. This collaboration helps bring innovative biotech products to market, benefitting both the biotech firms and patients needing advanced therapies.
The increasing demand for biologics & biosimilars, the growing outsourcing of biologics manufacturing by biopharmaceutical companies, the increasing emphasis on personalized medicine, the expansion of partnerships between pharmaceutical companies and biologics contract manufacturers, and technological developments in the manufacturing industry all contribute to the market's growth.
Additionally, the market for biotechnology contract manufacturing will see growth due to the increase in demand for cell and gene therapies and the expansion of CMOs' biologics production capabilities. However, because of the loss of strategic control and the lack of management monitoring, large companies view outsourcing as risky. As a result, big pharmaceutical corporations choose to keep their manufacturing processes internal. This is anticipated to provide certain growth-related challenges for biotechnology contract manufacturing.
The Biotechnology Contract Manufacturing Market is segmented on the basis of service, type, scale of operation, source, molecule, and therapeutic area. Based on the service, the market is segmented as Manufacturing, Formulation and Fill-Finish, Packaging and Labeling and Other services. Based on type, the market is segmented into Biologic Drug Substance Manufacturing and Biologic Drug Product Manufacturing.
By Scale of Operation, the market is divided into Commercial Operations and Clinical Operations. As per the source, the market is categorized into Mammalian Expression Systems and Non-Mammalian Expression Systems. By Molecule, the market is segmented into Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins and Other Molecule Types. On the basis of therapeutic area, the market is categorized into Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology and Other Therapeutic Areas.
The vaccine category commands a sizeable market share in the biotechnology contract manufacturing market. As monoclonal antibody therapy continues to advance, it is predicted to exhibit a similar pattern over the forecast period. The COVID-19 pandemic showed the manufacturing and outsourcing of vaccines had the potential to be a reliable source of income for businesses operating in the industry under investigation. After the COVID-19 vaccination, the addition of boosters is anticipated to make a favourable environment for the expansion of CMO vendors. The market growth under study is further aided by global campaigns by numerous governments and health organizations to offer immunizations to everyone.
The mammalian expression systems segment is projected to grow rapidly in the global biotechnology contract manufacturing market. Market growth is anticipated to be pushed by the extensive research being done on the use of different sources and species for biopharmaceutical development. Enhancing the productivity and efficiency of the biopharmaceutical manufacturing process is the fundamental goal of these investigations. Because of the higher cost involved in getting goods from these sources, mammalian-based biomanufacturing contributed to a higher revenue share.
The Asia Pacific biotechnology contract manufacturing market is expected to record the maximum market share in revenue. The development of the biotechnology contract manufacturing market in the Asia Pacific is attributed to the region's robust pharmaceutical and biotech industries, the presence of a well-established pharmaceutical industry, the rising demand for biologics and biosimilars, and the increasing outsourcing of manufacturing services by pharmaceutical and biopharmaceutical firms.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 20.5 Bn |
|
Revenue Forecast In 2034 |
USD 46.6 Bn |
|
Growth Rate CAGR |
CAGR of 8.7% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Service, By Type, By Scale of Operation, By Source, By Molecule, By Therapeutic Area |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Lonza (Switzerland), Samsung Biologics (South Korea), Thermo Fisher Scientific, Inc. (US), Catalent, Inc. (US), JSR Corporation (Japan), WuXi Biologics (China), AbbVie, Inc. (US), Boehringer Ingelheim International GmbH (Germany), Eurofins Scientific (Luxembourg), GenScript Biotech Corporation (US), AGC, Inc. (Japan), FUJIFILM Holding Corporation (Japan), Merck KgaA (Germany), Stelis, Recipharm Ab, Emergent, Shanghai Fosun Pharmaceutical Co., Ltd., Lotte Biologics, Hepalink Group, Curia Global, Inc., Jrs Pharma, Minapharm Pharmaceuticals, Rentschler Biopharma Se, Avid Bioservices, Inc., Abzena Ltd., Polyplus Transfection, Midas Pharma GMBH, Mabplex International Co., Ltd., Asahi Kasei Corporation |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biotechnology Contract Manufacturing Market Snapshot
Chapter 4. Global Biotechnology Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Estimates & Trend Analysis
5.1. By Service, & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Service:
5.2.1. Manufacturing
5.2.2. Formulation and Fill-Finish
5.2.3. Packaging and Labeling
5.2.4. Other services
Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis
6.1. By Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
6.2.1. Biologic Drug Substance Manufacturing
6.2.2. Biologic Drug Product Manufacturing
Chapter 7. Market Segmentation 3: By Scale of Operation Estimates & Trend Analysis
7.1. By Scale of Operation & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Scale of Operation:
7.2.1. Commercial Operations
7.2.2. Clinical Operations
Chapter 8. Market Segmentation 4: By Source Estimates & Trend Analysis
8.1. By Source & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Source:
8.2.1. Mammalian Expression Systems
8.2.2. Non-Mammalian Expression Systems
Chapter 9. Market Segmentation 5: By Molecule Estimates & Trend Analysis
9.1. By Molecule & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Molecule:
9.2.1. Monoclonal Antibodies
9.2.2. Cell Therapy & Gene Therapy
9.2.3. Antibody-Drug Conjugates (ADCs)
9.2.4. Vaccines
9.2.5. Therapeutic Peptides & Proteins
9.2.6. Other Molecule Types
Chapter 10. Market Segmentation 6: By Therapeutic Area Estimates & Trend Analysis
10.1. By Therapeutic Area & Market Share, 2024-2034
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Therapeutic Area:
10.2.1. Oncology
10.2.2. Autoimmune Diseases
10.2.3. Cardiovascular Diseases
10.2.4. Metabolic Diseases
10.2.5. Infectious Diseases
10.2.6. Neurology
10.2.7. Other Therapeutic Areas
Chapter 11. Biotechnology Contract Manufacturing Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Service, 2021-2034
11.1.2. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
11.1.3. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Scale of Operation, 2021-2034
11.1.4. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Source, 2021-2034
11.1.5. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Molecule, 2021-2034
11.1.6. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.1.7. North America Biotechnology Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
11.2. Europe
11.2.1. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Service, 2021-2034
11.2.2. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Type, 2021-2034
11.2.3. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Scale of Operation, 2021-2034
11.2.4. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Source, 2021-2034
11.2.5. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Molecule, 2021-2034
11.2.6. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) By Therapeutic Area, 2021-2034
11.2.7. Europe Biotechnology Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
11.3. Asia Pacific
11.3.1. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Service, 2021-2034
11.3.2. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Type, 2021-2034
11.3.3. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Scale of Operation, 2021-2034
11.3.4. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Source, 2021-2034
11.3.5. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Molecule, 2021-2034
11.3.6. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) By Therapeutic Area, 2021-2034
11.3.7. Asia Pacific Biotechnology Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
11.4. Latin America
11.4.1. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Service, (US$ Million) 2021-2034
11.4.2. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
11.4.3. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Scale of Operation, (US$ Million) 2021-2034
11.4.4. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Source, (US$ Million) 2021-2034
11.4.5. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Molecule, (US$ Million) 2021-2034
11.4.6. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2021-2034
11.4.7. Latin America Biotechnology Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
11.5. Middle East & Africa
11.5.1. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Service, (US$ Million) 2021-2034
11.5.2. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
11.5.3. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Scale of Operation, (US$ Million) 2021-2034
11.5.4. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Source, (US$ Million) 2021-2034
11.5.5. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Molecule, (US$ Million) 2021-2034
11.5.6. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2021-2034
11.5.7. Middle East & Africa Biotechnology Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1 Lonza (Switzerland)
12.2.2 Samsung Biologics (South Korea)
12.2.3 Thermo Fisher Scientific, Inc. (US)
12.2.4 Catalent, Inc. (US)
12.2.5 JSR Corporation (Japan)
12.2.6 WuXi Biologics (China)
12.2.7 AbbVie, Inc. (US)
12.2.8 Boehringer Ingelheim International GmbH (Germany)
12.2.9 Eurofins Scientific (Luxembourg)
12.2.10 GenScript Biotech Corporation (US)
12.2.11 AGC, Inc. (Japan)
12.2.12 FUJIFILM Holding Corporation (Japan)
12.2.13 Merck KgaA (Germany)
12.2.14 Stelis
12.2.15 Recipharm Ab
12.2.16 Emergent
12.2.17 Shanghai Fosun Pharmaceutical Co., Ltd.
12.2.18 Lotte Biologics
12.2.19 Hepalink Group
12.2.20 Curia Global, Inc.
12.2.21 Jrs Pharma
12.2.22 Minapharm Pharmaceuticals
12.2.23 Rentschler Biopharma Se
12.2.24 Avid Bioservices, Inc.
12.2.25 Abzena Ltd.
12.2.26 Polyplus Transfection
12.2.27 Midas Pharma GMBH
12.2.28 Mabplex International Co., Ltd.
12.2.29 Asahi Kasei Corporation
Biotechnology Contract Manufacturing Market By Service
Biotechnology Contract Manufacturing Market By Type
Biotechnology Contract Manufacturing Market By Scale of Operation
Biotechnology Contract Manufacturing Market By Source
Biotechnology Contract Manufacturing Market By Molecule
Biotechnology Contract Manufacturing Market By Therapeutic Area
Biotechnology Contract Manufacturing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
